Antibody data
- Antibody Data
- Antigen structure
- References [17]
- Comments [0]
- Validations
- Western blot [3]
- Immunocytochemistry [4]
- Immunohistochemistry [2]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA5-14291 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- MCM7 Monoclonal Antibody (47DC141 (DCS-141))
- Antibody type
- Monoclonal
- Antigen
- Recombinant full-length protein
- Description
- MA5-14291 targets CDC47 in IF, IHC (P), IP, and WB applications and shows reactivity with Canine, Human, mouse, Rat, and Xenopus laevis samples.
- Antibody clone number
- 47DC141 (DCS-141)
- Concentration
- 0.2 mg/mL
Submitted references Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy.
Combination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer model.
Evaluation of the effects of methotrexate released from polymeric implants in solid Ehrlich tumor.
Cell cycle-dependent formation of Cdc45-Claspin complexes in human cells is compromized by UV-mediated DNA damage.
Synonymous codon changes in the oncogenes of the cottontail rabbit papillomavirus lead to increased oncogenicity and immunogenicity of the virus.
Cell cycle-dependent mobility of Cdc45 determined in vivo by fluorescence correlation spectroscopy.
Encapsulation of cisplatin in long-circulating and pH-sensitive liposomes improves its antitumor effect and reduces acute toxicity.
Evaluation of minichromosome maintenance protein 7 as a prognostic marker in canine cutaneous mast cell tumours.
DNA mediated chromatin pull-down for the study of chromatin replication.
Rapamycin inhibits anal carcinogenesis in two preclinical animal models.
Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene.
Cell proliferation index predicts relapse of brain metastases in non-irradiated patients.
Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis.
Oxidative stress regulated expression of ubiquitin Carboxyl-terminal Hydrolase-L1: role in cell survival.
Identification, molecular cloning, and cellular distribution of the rat homolog of minichromosome maintenance protein 7 (MCM7) in the rat testis.
Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells.
Human cytomegalovirus prevents replication licensing by inhibiting MCM loading onto chromatin.
Béziat V, Rapaport F, Hu J, Titeux M, Bonnet des Claustres M, Bourgey M, Griffin H, Bandet É, Ma CS, Sherkat R, Rokni-Zadeh H, Louis DM, Changi-Ashtiani M, Delmonte OM, Fukushima T, Habib T, Guennoun A, Khan T, Bender N, Rahman M, About F, Yang R, Rao G, Rouzaud C, Li J, Shearer D, Balogh K, Al Ali F, Ata M, Dabiri S, Momenilandi M, Nammour J, Alyanakian MA, Leruez-Ville M, Guenat D, Materna M, Marcot L, Vladikine N, Soret C, Vahidnezhad H, Youssefian L, Saeidian AH, Uitto J, Catherinot É, Navabi SS, Zarhrate M, Woodley DT, Jeljeli M, Abraham T, Belkaya S, Lorenzo L, Rosain J, Bayat M, Lanternier F, Lortholary O, Zakavi F, Gros P, Orth G, Abel L, Prétet JL, Fraitag S, Jouanguy E, Davis MM, Tangye SG, Notarangelo LD, Marr N, Waterboer T, Langlais D, Doorbar J, Hovnanian A, Christensen N, Bossuyt X, Shahrooei M, Casanova JL
Cell 2021 Jul 8;184(14):3812-3828.e30
Cell 2021 Jul 8;184(14):3812-3828.e30
Combination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer model.
de Souza CM, Araújo e Silva AC, de Jesus Ferraciolli C, Moreira GV, Campos LC, dos Reis DC, Lopes MT, Ferreira MA, Andrade SP, Cassali GD
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2014 Feb;68(1):51-7
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2014 Feb;68(1):51-7
Evaluation of the effects of methotrexate released from polymeric implants in solid Ehrlich tumor.
de Fátima Pereira A, Mara da Costa V, Cristina Magalhães Santos M, Maciel de A Ribeiro RI, Gabriela Silva A, Carmo Horta Pinto F, Vieira Teixeira Vidigal P, Rodrigues Da Silva G
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2014 Apr;68(3):365-8
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2014 Apr;68(3):365-8
Cell cycle-dependent formation of Cdc45-Claspin complexes in human cells is compromized by UV-mediated DNA damage.
Broderick R, Rainey MD, Santocanale C, Nasheuer HP
The FEBS journal 2013 Oct;280(19):4888-902
The FEBS journal 2013 Oct;280(19):4888-902
Synonymous codon changes in the oncogenes of the cottontail rabbit papillomavirus lead to increased oncogenicity and immunogenicity of the virus.
Cladel NM, Budgeon LR, Hu J, Balogh KK, Christensen ND
Virology 2013 Apr 10;438(2):70-83
Virology 2013 Apr 10;438(2):70-83
Cell cycle-dependent mobility of Cdc45 determined in vivo by fluorescence correlation spectroscopy.
Broderick R, Ramadurai S, Tóth K, Togashi DM, Ryder AG, Langowski J, Nasheuer HP
PloS one 2012;7(4):e35537
PloS one 2012;7(4):e35537
Encapsulation of cisplatin in long-circulating and pH-sensitive liposomes improves its antitumor effect and reduces acute toxicity.
Leite EA, Souza CM, Carvalho-Júnior AD, Coelho LG, Lana AM, Cassali GD, Oliveira MC
International journal of nanomedicine 2012;7:5259-69
International journal of nanomedicine 2012;7:5259-69
Evaluation of minichromosome maintenance protein 7 as a prognostic marker in canine cutaneous mast cell tumours.
Berlato D, Stewart J, Newton R, Maglennon GA, Monti P, Flindall A, Murphy S
Veterinary and comparative oncology 2012 Jun;10(2):135-42
Veterinary and comparative oncology 2012 Jun;10(2):135-42
DNA mediated chromatin pull-down for the study of chromatin replication.
Kliszczak AE, Rainey MD, Harhen B, Boisvert FM, Santocanale C
Scientific reports 2011;1:95
Scientific reports 2011;1:95
Rapamycin inhibits anal carcinogenesis in two preclinical animal models.
Stelzer MK, Pitot HC, Liem A, Lee D, Kennedy GD, Lambert PF
Cancer prevention research (Philadelphia, Pa.) 2010 Dec;3(12):1542-51
Cancer prevention research (Philadelphia, Pa.) 2010 Dec;3(12):1542-51
Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene.
Jabbar SF, Abrams L, Glick A, Lambert PF
Cancer research 2009 May 15;69(10):4407-14
Cancer research 2009 May 15;69(10):4407-14
Cell proliferation index predicts relapse of brain metastases in non-irradiated patients.
Peev NA, Tonchev AB, Penkowa M, Kalevski SK, Haritonov DG, Chaldakov GN
Acta neurochirurgica 2008 Oct;150(10):1043-8; discussion 1048
Acta neurochirurgica 2008 Oct;150(10):1043-8; discussion 1048
Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis.
Balsitis S, Dick F, Dyson N, Lambert PF
Cancer research 2006 Oct 1;66(19):9393-400
Cancer research 2006 Oct 1;66(19):9393-400
Oxidative stress regulated expression of ubiquitin Carboxyl-terminal Hydrolase-L1: role in cell survival.
Shen H, Sikorska M, Leblanc J, Walker PR, Liu QY
Apoptosis : an international journal on programmed cell death 2006 Jun;11(6):1049-59
Apoptosis : an international journal on programmed cell death 2006 Jun;11(6):1049-59
Identification, molecular cloning, and cellular distribution of the rat homolog of minichromosome maintenance protein 7 (MCM7) in the rat testis.
Com E, Rolland AD, Guerrois M, Aubry F, Jégou B, Vallet-Erdtmann V, Pineau C
Molecular reproduction and development 2006 Jul;73(7):866-77
Molecular reproduction and development 2006 Jul;73(7):866-77
Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells.
Kingsbury SR, Loddo M, Fanshawe T, Obermann EC, Prevost AT, Stoeber K, Williams GH
Experimental cell research 2005 Sep 10;309(1):56-67
Experimental cell research 2005 Sep 10;309(1):56-67
Human cytomegalovirus prevents replication licensing by inhibiting MCM loading onto chromatin.
Wiebusch L, Uecker R, Hagemeier C
EMBO reports 2003 Jan;4(1):42-6
EMBO reports 2003 Jan;4(1):42-6
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot of CDC47 using CDC47 Monoclonal Antibody (Product # MA5-14291) on MAD109 Cells.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Knockdown of MCM7 was achieved by transfecting Caco-2 with MCM7 specific siRNAs (Silencer® select Product # s8602, s8603). Western blot analysis (Fig. a) was performed using whole cell extracts from the MCM7 knockdown cells (lane 3), non-specific scrambled siRNA transfected cells (lane 2) and untransfected cells (lane 1). The blots were probed with MCM7 Monoclonal Antibody (47DC141 or DCS-141) (Product # MA5-14291, 2µg/ml) and Goat anti-Mouse IgG (H+L) Superclonal™ Secondary Antibody, HRP conjugate (Product # A28177, 0.25 µg/ml 1:4000 dilution). Densitometric analysis of this western blot is shown in histogram (Fig. b). Decrease in signal upon siRNA mediated knock down confirms that antibody is specific to MCM7.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis was performed on modified whole cell extracts (1% SDS) (30 µg lysate) of PC-3 (Lane 1), LNCaP (Lane 2), DU 145 (Lane 3), HeLa (Lane 4) and MCF7 (Lane 5). The blot was probed with MCM7 Monoclonal Antibody (47DC141 or DCS-141) (Product # MA5-14291, 1µg/ml) and detected by chemiluminescence using Goat anti-Mouse IgG (H+L) Superclonal™ Secondary Antibody, HRP conjugate (Product # A28177, 0.25µg/ml, 1:4000 dilution). A 80kDa band corresponding to MCM7 was observed across the cell lines tested.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of MCM7 (green) showing staining in the nucleus of C2C12 cells (right) compared to a negative control without primary antibody (left). Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a MCM7 monoclonal antibody (Product # MA5-14291) in 3% BSA-PBS at a dilution of 1:20 and incubated overnight at 4ºC in a humidified chamber. Cells were washed with PBST and incubated with a DyLight-conjugated secondary antibody in PBS at room temperature in the dark. Actin was stained using Alexa Fluor 554 (red) and nuclei were stained with Hoechst or DAPI (blue). Images were taken at a magnification of 60x.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of MCM7 (green) showing staining in the nucleus of Hela cells (right) compared to a negative control without primary antibody (left). Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a MCM7 monoclonal antibody (Product # MA5-14291) in 3% BSA-PBS at a dilution of 1:20 and incubated overnight at 4ºC in a humidified chamber. Cells were washed with PBST and incubated with a DyLight-conjugated secondary antibody in PBS at room temperature in the dark. Actin was stained using Alexa Fluor 554 (red) and nuclei were stained with Hoechst or DAPI (blue). Images were taken at a magnification of 60x.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of MCM7 (green) showing staining in the nucleus of MCF-7 cells (right) compared to a negative control without primary antibody (left). Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a MCM7 monoclonal antibody (Product # MA5-14291) in 3% BSA-PBS at a dilution of 1:20 and incubated overnight at 4ºC in a humidified chamber. Cells were washed with PBST and incubated with a DyLight-conjugated secondary antibody in PBS at room temperature in the dark. Actin was stained using Alexa Fluor 554 (red) and nuclei were stained with Hoechst or DAPI (blue). Images were taken at a magnification of 60x.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescence analysis of MCM7 was performed using 70% confluent log phase DU 145 cells. The cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 15 minutes, and blocked with 1% BSA for 1 hour at room temperature. The cells were labeled with PLK1 Monoclonal Antibody (36-298) (Product # MA5-14291) at 5 µg/mL concentration in 0.1% BSA, incubated at 4 degree Celsius overnight and then labeled with Goat anti-Mouse IgG (H+L) Superclonal™ Secondary Antibody, Alexa Fluor® 488 conjugate (Product # A28175) for 45 minutes at room temperature (Panel a: green). Nuclei (Panel b: blue) were stained with ProLong™ Diamond Antifade Mountant with DAPI (Product # P36962). F-actin (Panel c: red) was stained with Rhodamine Phalloidin (Product # R415, 1:300). Panel d represents the merged image showing nuclear localization. Panel e represents control cells with no primary antibody to assess background. The images were captured at 60X magnification.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Formalin-fixed, paraffin-embedded human tonsil stained with CDC47 antibody using peroxidase-conjugate and DAB chromogen. Note nuclear staining of proliferating cells.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Formalin-fixed, paraffin-embedded rat breast carcinoma stained with CDC47 antibody using peroxidase-conjugate and AEC chromogen. Note nuclear staining of tumor cells.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunoprecipitation of CDC47 using CDC47 Monoclonal Antibody (Product # MA5-14291) on Native Human LS174T Cells.